Clinical trial Recruiting at 1 site Interventional

Adapting an online parenting program to help Pakistani teens stay mentally well

Official title: Cultural Adaptation and Randomized Controlled Trial Evaluation of an Online Parenting Intervention to Reduce the Risk of Depression and Anxiety in Adolescents

Run by Pakistan Institute of Living and Learning · NCT07790835 · Data updated 2026-11-12

A culturally adapted online parenting program is being tested to see if it can reduce depression symptoms in adolescents aged 12-18 in Pakistan when delivered to their parents.

More Depression, Anxiety trials

Quick facts

Study typeInterventional
SexAll
Enrollment1300 (estimated)
SponsorPakistan Institute of Living and Learning
Academic / other
Locations1 site (Karachi, Sindh)
StatusRecruiting
StartedOctober 26, 2026
Main results expectedSeptember 30, 2027
Study endsSeptember 30, 2027
Registry record updatedNovember 6, 2026
Trial IDNCT07790835 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are parents of a 12- to 18-year-old with internet access and basic literacy who consent to participate with one participating adolescent.

Probably not a fit

Adolescent-parent pairs with severe psychiatric illness, insufficient capacity to consent/assent, or temporary residency in the study city may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The trial adapts the Partners in Parenting program for a Pakistani context and tests its preliminary effectiveness in reducing adolescent depressive symptoms after three months. It uses a three-arm randomized design comparing the culturally adapted program to control conditions, with 1300 parent-adolescent dyads recruited from eight cities. The study begins with qualitative work to tailor content to local needs, involving adolescents, parents, grandparents, healthcare professionals, and teachers, and continues with a randomized controlled phase. Primary outcome is adolescent depressive symptoms measured by the Short Mood and Feelings Questionnaire (SMFQ).

Why it matters

Potential benefit: If successful, the program could help families support adolescent mental health and reduce depression risk in Pakistan.

How similar studies have gone: Previous studies of parent-focused online programs for adolescent mental health have shown promising signals but this Pakistan-specific adaptation is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria

1. Parents who have an adolescent aged 12-18 years. (If they have more than one child in this age bracket, only one child can participate that will be depend on their own willingness and mutual understanding).
2. Have sufficient internet literacy, access, and/or ability to read and write.
3. Only 1 parent-adolescent dyad/family will be eligible to participate, that will be depend on their own willingness and mutual understanding.

Exclusion Criteria

1. Presence of a diagnosed severe psychiatric disorder (e.g., bipolar disorder or Schizophrenia) or a severe physical illness in either the parent or adolescent that would significantly impair their ability to participate meaningfully in the study procedures.
2. Lack of capacity to provide informed consent (parent) or assent (adolescent), as determined by the trained research team.
3. Families who are temporary residents in the study city

Where it's running

  • Pakistan Institute of Living and Learning
    Karachi, Sindh, Pakistan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.